骨・関節用健康サプリメント市場：現状分析と予測（2022年～2028年）

世界の骨・関節用健康サプリメントの市場規模は、2022年から2028年の間に約8%のCAGRで成長すると予測されています。骨・関節用サプリメントの需要の高まりは、世界中でビタミンDやカルシウムなどの栄養補助食品に対する需要が増加していることに起因しています。さまざまな組成の関節用健康サプリメントの開発に対する市場関係者の関心の高まりは、市場成長を助けると考えられています。

当レポートでは、世界の骨・関節用健康サプリメント市場について調査し、COVID-19の影響、セグメント別の市場洞察、市場機会や動向、主要企業のプロファイルなどの情報を提供しています。

目次

第1章 市場イントロダクション

第2章 調査手法/前提条件

第3章 市場要約

第4章 エグゼクティブサマリー

第5章 COVID-19の骨・関節用健康サプリメント市場への影響

第6章 世界の骨・関節用健康サプリメント市場収益（2020年～2028年）

第7章 市場洞察：形状別

• ソフトジェル/ピル
• 粉末
• 液体
• その他

第8章 市場洞察：成分タイプ別

• ビタミン・ミネラル
• アミノ酸
• 植物性サプリメント
• その他

第9章 市場洞察：流通チャネル別

• 薬局・ドラッグストア
• 専門店
• オンライン
• その他

第10章 市場洞察：エンドユーザー別

• 男性
• 女性
• 子供

第11章 市場洞察：地域別

• 北米
  • 米国
  • カナダ
  • その他
• 欧州
  • ドイツ
  • 英国
  • フランス
  • イタリア
  • スペイン
  • その他
• アジア太平洋
  • 中国
  • 日本
  • オーストラリア
  • インド
  • その他
• その他の地域

第12章 骨・関節用健康サプリメント市場力学

• 市場促進要因
• 市場の課題
• 影響分析

第13章 骨・関節用健康サプリメントの市場機会

第14章 骨・関節用健康サプリメントの市場動向

第15章 需要側と供給側の分析

• 需要側分析
• 供給側分析

第16章 バリューチェーン分析

第17章 競合シナリオ

• 競合情勢
  • ポーターのファイブフォース分析

第18章 企業プロファイル

• Bayer AG
• Procter & Gamble Co
• Amway India Enterprises Pvt. Ltd.
• BBASF SE
• Archer-Daniels-Midland Co
• Pfizer Inc
• Reckitt Benckiser Group Plc
• Vita Life Sciences Limited
• Arazo Nutrition
• Glanbia plc

第19章 免責事項

The bone and joint health supplements market is expected to register a CAGR of approx. 8% over the period of 2022-2028. Bones and joint health ingredients such as collagen, calcium, magnesium, and chondroitin are considered essential compounds. These ingredients are used in functional foods to increase their beneficial effects. Bone and joint health ingredients aid in pain relief and joint and bone health by providing prebiotic fiber, vitamins such as vitamin D and vitamin K, calcium, and soy isoflavones. These bone and joint health ingredients aid in the flexibility and strength of the body's joints and bones. The growing demand for bone and joint health supplements can be attributed to the rise in the demand for nutritional supplements such as vitamin D, calcium, etc. across the globe. The increasing focus of the market players on the development of joint health supplements with different compositions is likely to aid the growth of the market. For instance, In November 2021, Nature's Bounty launched jelly beans vitamins that cater to a variety of wellness needs. Owing to the glaring statistics due to sedentary lifestyles there is a rise in joint discomfort among the growing population across the globe is leading to the growing demand for bone and joint health supplements and would contribute to the growth of the market in the forthcoming period as well. Furthermore, the bone and joint health supplements market is anticipated to grow on account of the increase in awareness regarding micronutrient deficiencies and a growing number of bone and joint-related issues among the geriatric population. However, some of the restraints in the market including the high cost of these healthy ingredients are impeding the growth of this market all over the world.

Bayer AG, Procter & Gamble Co, Amway India Enterprises Pvt. Ltd., BASF SE, Archer-Daniels-Midland Co, Pfizer Inc, Reckitt Benckiser Group Plc, Vita Life Sciences Limited, Arazo Nutrition, Glanbia plc are some of the key players in the market. Several M&As along with partnerships have been undertaken by these players to facilitate customers with hi-tech and innovative products/technologies.

Insights Presented in the Report:

"Amongst form, the soft gels/pills category accounted for the significant share in the market in 2020"

Based on the forms, the bone and joint health supplements market is segmented into soft gels/pills, powder, liquid, and others. The soft gels/pills segment accounted for a significant market share and it is estimated that it will grow rapidly during the projected timeframe. Pills are widely consumed on account of the easy availability of various dosage patterns, easy packaging techniques, storage, and cost-effectiveness. Additionally, soft gels/pills are also preferred in comparison to other types of nutritional supplements due to the high shelf life associated with them

"Amongst ingredient type, the vitamins & minerals category is expected to witness considerable CAGR during the forecast period"

Based on the ingredient type, the market is fragmented into vitamins & minerals, amino acids, botanical supplements, and others. The vitamins & minerals segment grabbed a considerable market share, and it is expected to grow at a significant CAGR during the forecast period owing to the growing adoption of healthy lifestyles, increasing life expectancy, and rising focus on active lifestyles. Also, the increasing consumption of vitamin D supplements to reduce the risk of bone fracture is impelling the market growth. Additionally, the growing adoption of mineral supplements to manage conditions such as osteoporosis and osteoarthritis is likely to aid the growth of the segment.

"Amongst distribution channels, the pharmacies drug stores category is expected to witness considerable CAGR during the forecast period"

Based on the distribution channel, the market is fragmented into pharmacies drug stores, specialty stores, online, and others. The pharmacies drug stores segment grabbed a considerable market share, and it is expected to grow at a significant CAGR during the forecast period owing to the rising number of pharmacy stores selling supplements for bone and joint health with a wide variety of product types of different brands. In, addition, the companies are investing in the opening of stores to reach a larger population base and meet the consumer demand, which is further contributing to the industry growth.

"Amongst end-users, the women category is expected to witness considerable CAGR during the forecast period"

Based on the end-users, the market is fragmented into men, women, and children. The women segment grabbed a considerable market share, and it is expected to grow at a significant CAGR during the forecast period. Women's bones are smaller and thinner than men. When menopause sets in, oestrogen, a hormone in women that protects bones, begins to drop off quickly, leading to bone loss due to which bone supplements are necessary for women and likely to boost the growth of the segment. The growing rate of osteoporosis among the women and geriatric population has raised the demand for calcium supplements which boosts the demand of the bone supplement market for women.

"North America to witness significant growth during the forecast period"

For a better understanding of the market dynamics of the bone and joint health supplements market, a detailed analysis was conducted for different regions across the globe including North America (the U.S, Canada, and the Rest of North America), Europe (Germany, France, Spain, United Kingdom, Italy, and Rest of Europe), Asia-Pacific (China, India, Australia, Japan, and Rest of APAC), Rest of World has been conducted. North America constitutes a major market for the bone and joint health supplements industry owing to the high demand from the elderly population due to joint discomfort and the increasing health-conscious population and their inclination toward functional food and beverages.

Reasons to buy this report:

The study includes market sizing and forecasting analysis validated by authenticated key industry experts.

The report presents a quick review of overall industry performance at one glance.

The report covers an in-depth analysis of prominent industry peers with a primary focus on key business financials, product portfolio, expansion strategies, and recent developments.

Detailed examination of drivers, restraints, key trends, and opportunities prevailing in the industry.

The study comprehensively covers the market across different segments.

Deep dive regional level analysis of the industry.

Customization Options:

Global bone and joint health supplements market can further be customized as per the requirement or any other market segment. Besides this, UMI understands that you may have your own business needs, hence feel free to connect with us to get a report that completely suits your requirements.

TABLE OF CONTENTS

1 MARKET INTRODUCTION

• 1.1. Market Definitions
• 1.2. Main Objective
• 1.3. Stakeholders
• 1.4. Limitation

2 RESEARCH METHODOLOGY OR ASSUMPTION

• 2.1. Research Process of the Bone and Joint Health Supplements Market
• 2.2. Research Methodology of the Bone and Joint Health Supplements Market
• 2.3. Respondent Profile

3 MARKET SYNOPSIS

4 EXECUTIVE SUMMARY

5 IMPACT OF COVID-19 ON THE BONE AND JOINT HEALTH SUPPLEMENTS MARKET

6 GLOBAL BONE AND JOINT HEALTH SUPPLEMENTS MARKET REVENUE (USD BN), 2020-2028F

7 MARKET INSIGHTS BY FORMS

• 7.1. Soft Gels/Pills
• 7.2. Powder
• 7.3. Liquid
• 7.4. Others

8 MARKET INSIGHTS BY INGREDIENTS TYPE

• 8.1. Vitamins & Minerals
• 8.2. Amino Acids
• 8.3. Botanical Supplements
• 8.4. Others

9 MARKET INSIGHTS BY DISTRIBUTION CHANNEL

• 9.1. Pharmacies Drug Stores
• 9.2. Specialty Stores
• 9.3. Online
• 9.4. Other

10 MARKET INSIGHTS BY END-USER

• 10.1. Men
• 10.2. Women
• 10.3. Children

11 MARKET INSIGHTS BY REGION

• 11.1. North America
  • 11.1.1. The U.S.
  • 11.1.2. Canada
  • 11.1.3. Rest of North America
• 11.2. Europe
  • 11.2.1. Germany
  • 11.2.2. The U.K.
  • 11.2.3. France
  • 11.2.4. Italy
  • 11.2.5. Spain
  • 11.2.6. Rest of Europe
• 11.3. Asia-Pacific
  • 11.3.1. China
  • 11.3.2. Japan
  • 11.3.3. Australia
  • 11.3.4. India
  • 11.3.5. Rest of Asia-Pacific
• 11.4. Rest of World

12 BONE AND JOINT HEALTH SUPPLEMENTS MARKET DYNAMICS

• 12.1. Market Drivers
• 12.2. Market Challenges
• 12.3. Impact Analysis

13 BONE AND JOINT HEALTH SUPPLEMENTS MARKET OPPORTUNITIES

14 BONE AND JOINT HEALTH SUPPLEMENTS MARKET TRENDS

15 DEMAND AND SUPPLY SIDE ANALYSIS

• 15.1. Demand Side Analysis
• 15.2. Supply Side Analysis

16 VALUE CHAIN ANALYSIS

17 COMPETITIVE SCENARIO

• 17.1. Competitive Landscape
  • 17.1.1. Porter's Five Forces Analysis

18 COMPANY PROFILED

• 18.1. Bayer AG
• 18.2. Procter & Gamble Co
• 18.3. Amway India Enterprises Pvt. Ltd.
• 18.4. BASF SE
• 18.5. Archer-Daniels-Midland Co
• 18.6. Pfizer Inc
• 18.7. Reckitt Benckiser Group Plc
• 18.8. Vita Life Sciences Limited
• 18.9. Arazo Nutrition
• 18.10. Glanbia plc

19 DISCLAIMER